EURUSD Trendline After the bullish divergence in the oversold area:
Now the EURUSD pair is forming an upside trendline to the next resistance.
Looking forward to read your opinion about it.
Buy-signal
WAR Westarter crypto project incubator 35X Upside Potential !!!WAR WeStarter is a cross-chain token initial swap platform which selects high-quality crypto projects that need fundraising before listing to major exchanges.
A similar incubator is SFUND Seedify, that has a mk cap of 192Mil.
WAR Westarter mk cap is only 5.5Mil.
The upside potential is 35X from here just to reach SFUND`s market cap.
on Monday they will burn 13% of their total supply.
Extremely low circulating supply.
This is a premium call in my opinion. Minimum upside potential is 10X i think.
BBIG Vinco Ventures owns the new TikTok ??BBIG Vinco Ventures owns an 80% stake in Lomotif.
Lomotif is a video sharing site that similar to TikTok.
Lomotif has more than 31 million on-platform monthly active users.
Now imagine that TikTok could be banned from the US due to data security issues - we`ve heard that discussion before.
Lomotif is here to take its place.
My short term price target is $5.5 and $8.7 for Q3.
What do you think about Lomotif??
WNW from $160 to $2.09Wunong Net Technology Company Limited Changed its name to Meiwu Technology Company Limited
Xinliang Zhang, CEO of the Company: “The Company’s new name better reflects the Company’s international business line beyond its Wunong Net business as a global high-tech internet trading platform with a global commodity chain and the comprehensive services such as online consultation, display, sales and after-sales services. We are excited about our development in this new chapter.”
This is a speculative buy.
MITC the next Beyond Meat ???Dec. 7, 2021 Sharon Fima, CEO and CTO, MeaTech3D:
“Today’s breakthrough is the culmination of over one year’s efforts in our cellular biology and high-throughput tissue engineering processes, as well as our precision bioprinting technology. By bioprinting a 3.67 oz steak comprised of living tissue, we believe we have both validated our core technologies and placed ourselves at the forefront of the race to develop high-end, real cell-based cultivated premium meat products.”
I think MeaTech3D has the potential to rival BYND at some point.
52 Week Range 4.81 - 11.79
Market Cap of only 84.347M
MBRX Annamycin Fast Track and Orphan Drug Designation from FDAMoleculin Biotech`s Annamycin has Fast Track Status and Orphan Drug Designation from FDA for the treatment of soft tissue sarcoma lung metastases.
the FDA agreed with Moleculin Biotech`s Investigational New Drug (IND) application to study WP1122 for the treatment of Glioblastoma Multiforme (GBM) to go forward.
This should be an interesting year for MBRX, which is at all time low now.
52 Week Range 1.64 - 8.78
My price target is $3.8
GLBS all time low! Cheap company in the global shipping sectorGlobus Maritime has nine dry bulk carriers in the spot market.
Globus Maritime can benefited from the significant increase in global shipping rates because of the surge in demand for goods and a lack of capacity across the industry!
I wouldn`t be surprised to see it jump at $4.5 this year.
AEZS European approval to market MacrillenAEterna has a variety of new products in its pipeline.
Macrilen, for example, is the first and only FDA-approved oral test for the diagnosis of Adult Growth Hormone Deficiency.
AEterna received European approval to market Macrillen.
Dr. Christian Strasburger: "Clinical studies have demonstrated that macimorelin is safer and much simpler to administer than the current methods of testing for insulin-induced hypoglycemia, and is well-tolerated by patients and reliable in diagnosing the condition.”
I think AEZS is a sleeping giant.
My price target is $1.25.
TORN Oversold at SupportTORN offers non-custodial anonymous transactions on Ethereum.
Now the asset is oversold on a strong support line.
We can see a bounce from here!
RAMPUSDT oversoldRAMP is the multi-chain DeFi lending platform that maximizes capital efficiency on assets.
Ramp aims to empower users with access to a global, blockchain-agnostic liquidity network. rUSD can be minted on Binance Smart Chain and Polygon, with more chains in the near future.
now is sitting oversold at a support area. looks like an interesting buy opportunity.
CWBR Upside PotentialCWBR closed 2 months ago a $15.0 Million Public Offering of Common Stock and Warrants at $0.72, so this is a safe upside in my opinion if you want to enter now.
On the other hand, Cantor Fitzgerald brokerage has a $2.5 price target for it.
52 Week Range 0.34 - 2.27 Just bounced from its lowest support.
KMPH $50 Million Share Repurchase ProgramWhen most of the companies are diluting their shares and insiders are selling, KemPharm, Inc. (KMPH) does the opposite.
Insiders are buying and the Board of Directors authorizes a program to repurchase up to $50 million of the Company’s outstanding stock valid through December 31, 2023. It is equivalent to 18% of KemPharm’s current market capitalization.
Because of the short term puts i have 2 approaches for KMPH:
dump to 7.17 and then go to 11.45
or
bounce from the strong support which it has right now and go to $14.50
Looking forward to read your opinion about it.
Novonix ST: the upside prevails as long as 9.20 is support.Alternative scenario: the downside breakout of 9.20 would call for 7.10.
My pivot point stands at 8.20.
My preference: the upside prevails as long as 0.20 is support.
Comment:
the RSI is above its neutrality area at 50.
The MACD is positive and above its signal line.
The configuration is positive.
Moreover, the stock is trading above both its 20 and 50 day moving average (respectively at 9.11 and 9.11).
Trade Safe -
Jimster45
FTM Fantom bounced from supportFTM Fantom bounced from the strong support and it looks to aim higher.
But what is FTM?
Fantom is a fast, high-throughput open-source smart contract platform for digital assets and dApps.
Fantom’s aBFT consensus protocol delivers unparalleled speed, security, and reliability.
Enjoy almost instant transactions and extremely low fees.
Looking forward to read your opinion about it.
LINK/BTC HAS BOTTOMED! BUY NOW?I personally think LINK/BTC has bottomed and I’ll be adding some here for my spot holdings.
(SPOT trade🚨)
TP1 = $0.00104 🎯
TP2 = $0.001692 🎯
TP3 = $0.00303 🎯
Trade safe ~ BYA
FTFT New Blockchain Division | digital currency trading serviceThe blockchain division purpose is to develop, operate and manage the Company's previously announced bitcoin mining farm in the United States and Paraguay and to coordinate its announced Dubai-based digital currency trading service and crypto asset management.
My price target is the 3.15 resistance.
QNRX first FDA-approved treatment for Netherton SyndromeQuoin Pharmaceuticals (NASDAQ: QNRX ) is positioned to deliver the first FDA-approved treatment for Netherton Syndrome, a devastating disorder which affects 1 in every 200,000 people worldwide.
This month, QNRX Signed Multiple Exclusive Distribution Agreements for in various regions of the globe for its Lead Asset, QRX003, for Netherton Syndrome.
JMP Securities Initiated Coverage on Quoin Pharmaceuticals, Ltd. ( QNRX ) with a Market Outperform rating and a price target of 8usd.
QNRX is massively oversold having a bullish divergence chart formation and fundamentals that can skyrocket the price to 12 usd in my opinion!
Could be a Great buy opportunity at $1.91 today!
GBPCAD (LONG) SignalLong position on GBPCAD bit late to posting as price has already moved away from my entry. Bullish engulfing candle supports the initial idea.
USDCAD: $1.30 Upside TAnticipating $1.30 to deliver by Tuesday EOD.
Been a successful week since last post.
+300 points.
Happy Holidays
:)
FWBI all time lowFirst Wave BioPharma is a clinical-stage biopharmaceutical company that specializes in the development of targeted, non-systemic therapies for gastrointestinal diseases.
52 Week Range 1.27 - 26.30
Now the price is close to all time low and looks like a buy opportunity!
CWBR antiaging stock Price Target I think antiaging stocks will be the new FAANGS in 5 to 10 years.
Immortality here, on earth, is the next frontier for the medicine.
CohBar is developing mitochondria-based therapeutics for the treatment of chronic and age-related diseases.
On 11/12/2021 Cantor Fitzgerald brokerage Initiated Coverage on CWBR with an Overweight rating and a price target of $2.50.
This all time low looks like a great buy opportunity for me.
Looking forward to read your opinion on it.
ASTR Launch for NASA from Cape Canaveral in JanuaryAstra Space, Inc. (ASTR) to deploy its first satellite in orbit for the National Aeronautics and Space Administration (NASA) in January 2022.
At this price before this big upcoming catalyst, this looks like a great buying opportunity!
My short term price target is 11.8usd.
Looking forward to read your opinion about it.
